Combined treatment with an AT1 receptor blocker and angiotensin converting enzyme inhibitor has an additive effect on inhibiting neointima formation via improvement of nitric oxide production and suppression of oxidative stress.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Hypertension Research

• Publication date

  2004-02-01

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1291/HYPRES.27.129PMID 15005276
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Angiotensin II and Catecholamines Increase Plasma Levels of 8-Epi-Prostaglandin F2&agr; With Different Pressor Dependencies in Rats

  2002cited by this paper
• Beneficial Effects of Combined Blockade of ACE and AT1 Receptor on Intimal Hyperplasia in Balloon-Injured Rat Artery

  2002cited by this paper
• Soluble Guanylate Cyclase &agr;1 and &bgr;1 Gene Transfer Increases NO Responsiveness and Reduces Neointima Formation After Balloon Injury in Rats via Antiproliferative and Antimigratory Effects

  2001cited by this paper
• Comparative Effect of ACE Inhibition and Angiotensin II Type 1 Receptor Antagonism on Bioavailability of Nitric Oxide in Patients With Coronary Artery Disease: Role of Superoxide Dismutase

  2001cited by this paper
• Cardioprotection with angiotensin converting enzyme inhibitor and angiotensin II type 1 receptor antagonist is not abolished by nitric oxide synthase inhibitor in ischemia-reperfused rabbit hearts.

  2001cited by this paper
• Valsartan for prevention of restenosis after stenting of type B2/C lesions: the VAL-PREST trial.

  2001cited by this paper
• Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure : role of nitric oxide, prostanoids, oxidant stress, and bradykinin.

  2000cited by this paper
• Phenotypic Modulation by Fibronectin Enhances the Angiotensin II–Generating System in Cultured Vascular Smooth Muscle Cells

  2000cited by this paper
• Phenotypic modulation by fibronectin enhances the angiotensin II-generating system in cultured vascular smooth muscle cells.

  2000cited by this paper
• Improvement of Endothelial Function by Chronic Angiotensin-Converting Enzyme Inhibition in Heart Failure

  2000cited by this paper
• Modulation of vascular development and injury by angiotensin II.

  1999cited by this paper
• Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure.

  1999cited by this paper
• Combination ACE Inhibitor and Angiotensin II Receptor Antagonist Therapy in Diabetic Nephropathy

  1999cited by this paper
• Production of Angiotensin II by Homogeneous Cultures of Vascular Smooth Muscle Cells From Spontaneously Hypertensive Rats

  1999cited by this paper
• Production of angiotensin II by homogeneous cultures of vascular smooth muscle cells from spontaneously hypertensive rats.

  1999cited by this paper
• Pathophysiological Role of Angiotensin II Type 2 Receptor in Cardiovascular and Renal Diseases

  1998cited by this paper
• Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases.

  1998cited by this paper
• Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats.

  1998cited by this paper
• Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns.

  1998cited by this paper
• Cardiac angiotensin II receptors are upregulated by long-term inhibition of nitric oxide synthesis in rats.

  1998cited by this paper
• Elevated vascular angiotensin converting enzyme mediates increased neointima formation after balloon injury in spontaneously hypertensive rats

  1997cited by this paper
• Induction of renin in medial smooth muscle cells by balloon injury.

  1997cited by this paper
• Angiotensin II-induced progression of neointimal thickening in the balloon-injured rat carotid artery is AT1 receptor mediated.

  1996influential reference
• Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction

  1995cited by this paper
• Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.

  1995cited by this paper
• Angiotensin II type 1 receptor blockade inhibits the expression of immediate-early genes and fibronectin in rat injured artery.

  1995cited by this paper
• The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.

  1995cited by this paper
• Effect of high dose angiotensin-converting enzyme inhibition on restenosis: Final results of the MARCATOR study, a multicenter, double-blind, placebo-controlled trial of cilazapril

  1995cited by this paper
• Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.

  1994cited by this paper
• Potential Importance of Tissue Angiotensin‐Converting Enzyme Inhibition in Preventing Neointima Formation

  1994cited by this paper
• Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation.

  1993cited by this paper
• Vascular Injury Induces Angiotensinogen Gene Expression in the Media and Neointima

  1993cited by this paper
• Activation of two angiotensin‐generating systems in the balloon‐injured artery

  1993cited by this paper
• Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angiopla

  1992cited by this paper
• Angiotensin-converting enzyme inhibitor versus angiotensin II, AT1 receptor antagonist. Effects on smooth muscle cell migration and proliferation after balloon catheter injury.

  1991cited by this paper
• Losartan, a nonpeptide angiotensin II (Ang II) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteries.

  1991influential reference
• Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury.

  1989cited by this paper
• Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle growth in chronically denuded vessels.

  1986cited by this paper
• Effects of Tonin, an Angiotensin II‐Forming Enzyme, on Vascular Smooth Muscle in the Normal Rabbit

  1981cited by this paper

• Angiotensin converting enzyme inhibitors and angiotensin receptor blockers have no effect on the outcomes of endovascular revascularization in tibial arterial occlusive disease.

  2020cites this paper
• Hypertension and Cardiovascular Mortality in Patients with Cushing Syndrome.

  2019cites this paper
• Pathogenesis and Prevention of Vascular Access Failure

  2019cites this paper
• Should ACE inhibitors and ARBs be used in combination in children?

  2018cites this paper
• An overview of the emerging interface between cardiac metabolism, redox biology and the circadian clock.

  2018cites this paper
• Relative risk factors of patients with coronary heart disease combined with renal artery stenosis

  2017cites this paper
• Reactive Oxygen Species: A Key Hallmark of Cardiovascular Disease

  2016cites this paper
• Angiotensin Converting-Enzyme Inhibitors, Angiotensin Receptor Blockers, and Calcium Channel Blockers Are Associated with Prolonged Vascular Access Patency in Uremic Patients Undergoing Hemodialysis

  2016cites this paper
• Redox Roles of Reactive Oxygen Species in Cardiovascular Diseases

  2015cites this paper
• Repetitive hypoglycemia increases circulating adrenaline level with resultant worsening of intimal thickening after vascular injury in male Goto-Kakizaki rat carotid artery.

  2014cites this paper
• Ramipril and Valsartan as Protective Agents against Some Complications of an Experimentally Induced Obesity in Rats

  2014cites this paper
• Carotid Artery Intima-Media Thickness and the Renin-Angiotensin System

  2013cites this paper
• Endothelial Dysfunction in Diabetes and Hypertension: Cross Talk in RAS, BMP4, and ROS-dependent COX-2–derived Prostanoids

  2013cites this paper
• Oxidative stress in hypertensive children before and after 1 year of antihypertensive therapy

  2012cites this paper
• Angiotensin receptor blockers and antiplatelet agents are associated with improved primary patency after arteriovenous hemodialysis access placement.

  2011cites this paper
• Renal (pro)renin receptor contributes to development of diabetic kidney disease through transforming growth factor‐β1 – connective tissue growth factor signalling cascade

  2011cites this paper
• (Pro)renin receptor contributes to diabetic nephropathy by enhancing renal inflammation

  2010cites this paper
• Valsartan and Amlodipine: Safety and Efficacy in Stroke Prevention

  2010cites this paper
• [Pathomechanism of diabetic neuropathy: background of the pathogenesis-oriented therapy].

  2010cites this paper
• A neuropathia diabetica patomechanizmusa: az oki kezelés elméleti háttere

  2010cites this paper
• A neuropathia diabetica patomechanizmusa: az oki kezelés elméleti háttere

  2010cites this paper
• A neuropathia diabetica patomechanizmusa: az oki kezelés elméleti háttere Pathomechanism of diabetic neuropathy:

  2010cites this paper
• A neuropathia diabetica patomechanizmusa: az oki kezelés elméleti háttere Pathomechanism of diabetic neuropathy:

  2010cites this paper
• Effects of mineralocorticoid and angiotensin II receptor blockers on proteinuria and glomerular podocyte protein expression in a model of minimal change nephrotic syndrome

  2010cites this paper
• Effects of angiotensin-II receptor blockers on experimental autoimmune myocarditis.

  2009cites this paper
• The Renin-Angiotensin-Aldosterone System as a Therapeutic Target for Endothelial Dysfunction

  2009cites this paper
• Carotid Artery Disease: Current Concepts on Endothelial Dysfunction and Matrix Remodeling

  2009cites this paper
• Candesartan Decreases Carotid Intima-Media Thickness by Enhancing Nitric Oxide and Decreasing Oxidative Stress in Patients with Hypertension

  2008cites this paper
• Effects of Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Antagonist Combination on Nitric Oxide Bioavailability and Atherosclerotic Change in Watanabe Heritable Hyperlipidemic Rabbits

  2008cites this paper
• Enalapril and Losartan Are More Effective Than Carvedilol in Preventing Dilated Cardiomyopathy in the Syrian Cardiomyopathic Hamster

  2008cites this paper
• Candesartan and Insulin Reduce Renal Sympathetic Nerve Activity in Hypertensive Type 1 Diabetic Rats

  2008cites this paper
• Beneficial Effects of Combination Therapy with Angiotensin II Receptor Blocker and Angiotensin-Converting Enzyme Inhibitor on Vascular Endothelial Function

  2008cites this paper
• Increased Expression of Angiotensin Converting Enzyme 2 in Conjunction with Reduction of Neointima by Angiotensin II Type 1 Receptor Blockade

  2008cites this paper
• Cardiac and Vascular Renin-Angiotensin Systems

  2007cites this paper
• Effects of Monotherapy of Temocapril or Candesartan with Dose Increments or Combination Therapy with Both Drugs on the Suppression of Diabetic Nephropathy

  2007cites this paper
• Superimposing candesartan onto ACE inhibition slows renal function decline in nondiabetic chronic kidney disease

  2007cites this paper
• Vascular Angiotensin Type 1 Receptor Expression Is Associated with Vascular Dysfunction, Oxidative Stress and Inflammation in Fructose-Fed Rats

  2007cites this paper
• Endothelial vascular function in hypertensive patients after renin-angiotensin system blockade.

  2006cites this paper
• Effects of Angiotensin II Type 1 Receptor Blockade on the Systemic Blood Nitric Oxide Dynamics in Nω-Nitro-L-Arginine Methyl Ester–Treated Rats

  2006cites this paper
• Inhibition of Inward Rectifier K+ Currents by Angiotensin II in Rat Atrial Myocytes: Lack of Effects in Cells from Spontaneously Hypertensive Rats

  2006cites this paper
• Endothelial Vascular Function in Hypertensive Patients After Renin—Angiotensin System Blockad

  2006cites this paper
• [Hypertension combined with atherosclerotic lesions in carotid arteries: should angiotensin converting enzyme inhibitors be prescribed?].

  2005cites this paper
• Predictors of Undiagnosed Renal Artery Stenosis among Japanese Patients with Risk Factors of Atherosclerosis

  2005cites this paper
• Long-term dual blockade with candesartan and lisinopril in hypertensive patients with diabetes: the CALM II study.

  2005cites this paper
• Glucocorticoid excess and hypertension

  2004cites this paper
• Dual blockade of the renin angiotensin system in diabetic and nondiabetic kidney disease

  2004cites this paper